Cite
Enhanced efficacy of propranolol therapy for infantile hemangiomas based on a mesoporous silica nanoplatform through mediating autophagy dysfunction.
MLA
Wu, Haiwei, et al. “Enhanced Efficacy of Propranolol Therapy for Infantile Hemangiomas Based on a Mesoporous Silica Nanoplatform through Mediating Autophagy Dysfunction.” Acta Biomaterialia, vol. 107, Apr. 2020, pp. 272–85. EBSCOhost, https://doi.org/10.1016/j.actbio.2020.02.033.
APA
Wu, H., Wang, X., Liang, H., Zheng, J., Huang, S., & Zhang, D. (2020). Enhanced efficacy of propranolol therapy for infantile hemangiomas based on a mesoporous silica nanoplatform through mediating autophagy dysfunction. Acta Biomaterialia, 107, 272–285. https://doi.org/10.1016/j.actbio.2020.02.033
Chicago
Wu, Haiwei, Xuan Wang, Hao Liang, Jiawei Zheng, Shengyun Huang, and Dongsheng Zhang. 2020. “Enhanced Efficacy of Propranolol Therapy for Infantile Hemangiomas Based on a Mesoporous Silica Nanoplatform through Mediating Autophagy Dysfunction.” Acta Biomaterialia 107 (April): 272–85. doi:10.1016/j.actbio.2020.02.033.